Does intravenous (IV) methylprednisolone cause elevated white blood cell (WBC) and neutrophil counts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does IV Methylprednisolone Cause Elevated WBC and Neutrophil Counts?

Yes, IV methylprednisolone causes a well-established, dose-dependent increase in white blood cell count, predominantly through neutrophil elevation (neutrophilia), which can occur as early as the first day of treatment and persist throughout therapy. 1

Mechanism of Leukocytosis

The neutrophilia induced by methylprednisolone occurs through multiple mechanisms:

  • Demargination of neutrophils: Methylprednisolone reduces neutrophil adhesion molecule expression, specifically decreasing Mac-1 (CD11b) by 35-51% and L-selectin (CD62L) by 17-31% within 6 hours of administration. 2, 3 This causes marginated neutrophils to detach from vessel walls and enter the circulation.

  • Reduced neutrophil migration: The decreased expression of adhesion molecules impairs the capacity of neutrophils to migrate from the vasculature into tissues. 2

  • Increased granulocyte production: Methylprednisolone induces granulocyte-colony stimulating factor (G-CSF), which increases by threefold at 6 hours, contributing to neutrophil production and release from bone marrow. 2

Expected Magnitude and Timeline

Typical response pattern after IV methylprednisolone:

  • At 6 hours: Neutrophil counts increase approximately threefold (200-300% of baseline), with WBC rising by 23-30%. 2, 3

  • At 24 hours: Neutrophil counts remain elevated at approximately twofold (200% of baseline). 2

  • Percentage shift: The neutrophil percentage increases from baseline (e.g., from 54.6% to 58.1%). 3

  • Absolute increases: Expect increases of approximately 4,000-4,600 neutrophils/mm³ above baseline with doses of 200-400 mg hydrocortisone equivalent. 4

  • Recovery: All parameters typically return to baseline levels within 48 hours after completing a 5-day therapeutic course. 2

Clinical Implications and Pitfalls

Critical distinction from infection:

  • Check peripheral smear: Look specifically for left shift (>6% bands) and toxic granulation to distinguish steroid-induced leukocytosis from infection. 1

  • Investigate for infection if: WBC >14,000/mm³ AND left shift is present, regardless of steroid dose. 1

  • Magnitude matters: Even small doses of prednisone administered over prolonged periods can induce extreme and persistent leukocytosis. 1

  • Fever may be absent: Maintain heightened vigilance for occult infection in immunosuppressed patients on chronic steroids, even without fever, as leukocytosis may be blunted or absent in truly infected immunocompromised patients. 1

Lymphocyte effects:

  • Corticosteroids are lymphocyte-depleting agents, so while neutrophils increase, lymphocyte counts may decrease. 5, 1

  • Absolute lymphocyte and eosinophil counts typically do not change significantly or may decrease. 3

Practical Monitoring Recommendations

When patients receive IV methylprednisolone (e.g., 30 mg every 12 hours or 100 mg every 6 hours for acute severe ulcerative colitis 5, or 1 g daily for 3 days for severe immune-related adverse events 5):

  • Expect neutrophilia: Anticipate WBC elevation of 4,000-6,000 cells/mm³ within 6-24 hours.

  • Do not reflexively treat: Isolated neutrophilia without left shift, fever, or clinical signs of infection does not require antibiotics.

  • Serial monitoring: If infection is suspected, follow serial WBC counts with differential and assess clinical trajectory rather than relying on a single elevated value.

  • Consider prophylaxis: For patients on chronic high-dose steroids, consider Pneumocystis jirovecii prophylaxis and maintain vigilance for opportunistic infections. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.